In the last trading session, 1.29 million shares of the Atyr Pharma Inc (NASDAQ:ATYR) were traded, and its beta was 1.10. Most recently the company’s share price was $3.53, and it changed around $0.17 or 5.06% from the last close, which brings the market valuation of the company to $304.48M. ATYR currently trades at a discount to its 52-week high of $3.80, offering almost -7.65% off that amount. The share price’s 52-week low was $1.14, which indicates that the current value has risen by an impressive 67.71% since then. We note from Atyr Pharma Inc’s average daily trading volume that its 10-day average is 0.68 million shares, with the 3-month average coming to 899.72K.
Atyr Pharma Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 0 recommended ATYR as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Atyr Pharma Inc is expected to report earnings per share of -0.23 for the current quarter.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Instantly ATYR has showed a green trend with a performance of 5.06% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.78 on recent trading dayincreased the stock’s daily price by 6.61%. The company’s shares are currently up 150.35% year-to-date, but still down -0.84% over the last five days. On the other hand, Atyr Pharma Inc (NASDAQ:ATYR) is 13.87% up in the 30-day period. We can see from the shorts that 2.11 million shares have been sold at a short interest cover period of 1.78 day(s).
Atyr Pharma Inc (ATYR) estimates and forecasts
Atyr Pharma Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 82.90 percent over the past six months and at a 5.32% annual growth rate that is well below the industry average of 17.10%. The year-over-year growth rate is expected to be -49.48%, down from the previous year.
Forecasts for the next quarter put sales growth at -100.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 43.36%. Atyr Pharma Inc earnings are expected to increase by 2.79% in 2024, but the outlook is positive 13.00% per year for the next five years.
ATYR Dividends
Atyr Pharma Inc’s next quarterly earnings report is expected to be released in January.
